Elevated level of C‐reactive protein may be an early marker to predict risk for severity of COVID‐19

Posted on | Posted on John Murphy | Leave a Comment on Elevated level of C‐reactive protein may be an early marker to predict risk for severity of COVID‐19

Authors: Nurshad Ali 1 The outbreak of coronavirus disease‐2019 (COVID‐19) is an emerging global health threat. The healthcare workers are facing challenges in reducing the severity and mortality of COVID‐19 across the world. Severe patients with COVID‐19 are generally treated in the intensive care unit, while mild or non‐severe patients treated in the usual isolation ward […]

The role of C-reactive protein as a prognostic marker in COVID-19

Posted on | Posted on John Murphy | Leave a Comment on The role of C-reactive protein as a prognostic marker in COVID-19

Authors: Dominic Stringer,1Philip Braude,2Phyo K Myint,3Louis Evans,4Jemima T Collins,5Alessia Verduri,6Terry J Quinn,7Arturo Vilches-Moraga,8Michael J Stechman,9Lyndsay Pearce,10Susan Moug,11Kathryn McCarthy,12Jonathan Hewitt,13 and Ben Carter1 Abstract Background C-reactive protein (CRP) is a non-specific acute phase reactant elevated in infection or inflammation. Higher levels indicate more severe infection and have been used as an indicator of COVID-19 disease severity. However, the […]

High sensitivity troponin and COVID-19 outcomes

Posted on | Posted on John Murphy | Leave a Comment on High sensitivity troponin and COVID-19 outcomes

Authors: Nikolaos Papageorgiou,a,bCatrin Sohrabi,aDavid Prieto Merino,c,dAngelos Tyrlis,aAbed Elfattah Atieh,aBunny Saberwal,aWei-Yao Lim,aAntonio Creta,aMohammed Khanji,aReni Rusinova,aBashistraj Chooneea,aRaj Khiani,d,eNadeev Wijesuriya,e,fAnna Chow,e,fHaroun Butt,e,fStefan Browne,e,fNikhil Joshi,e,fJamie Kay,e,fSyed Ahsan,a and Rui Providenciaa,g Abstract Background Recent reports have demonstrated high troponin levels in patients affected with COVID-19. In the present study, we aimed to determine the association between admission and peak troponin levels and […]

Clinical utility of cardiac troponin measurement in COVID-19 infection

Posted on | Posted on John Murphy | Leave a Comment on Clinical utility of cardiac troponin measurement in COVID-19 infection

Authors: David C Gaze 1 2 Abstract The novel coronavirus SARS-CoV-2 causes the disease COVID-19, a severe acute respiratory syndrome. COVID-19 is now a global pandemic and public health emergency due to rapid human-to-human transmission. The impact is far-reaching, with enforced social distancing and isolation, detrimental effects on individual physical activity and mental wellbeing, education in the […]

Troponin and BNP Use in COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Troponin and BNP Use in COVID-19

Mar 18, 2020 Cardiology Magazine Authors: James L. Januzzi Jr., MD, FACC What are the potential mechanisms underlying troponin elevation with COVID-19 infection? Rise and/or fall of troponin indicating myocardial injury is common among patients with acute respiratory infections and correlated with disease severity.  Abnormal troponin values are common among those with COVID-19 infection particularly […]

Cardiac Troponin-I and COVID-19: A Prognostic Tool for In-Hospital Mortality

Posted on | Posted on John Murphy | Leave a Comment on Cardiac Troponin-I and COVID-19: A Prognostic Tool for In-Hospital Mortality

Authors: Baher Al Abbasi 1, Pedro Torres 1, Fergie Ramos-Tuarez 2, Nakeya Dewaswala 1, Ahmed Abdallah 1, Kai Chen 1, Mohamed Abdul Qader 1, Riya Job 1, Samar Aboulenain 1, Karolina Dziadkowiec 1, Huzefa Bhopalwala 3, Jesus E Pino 2, Robert D Chait 2 Abstract Background: The number of fatalities due to coronavirus disease 2019 (COVID-19) is escalating with more than 800,000 deaths globally. The scientific community remains in urgent need of prognostic tools to determine the probability of survival in […]

More than 1,000 COVID-19 deaths recorded as US returns to April levels

Posted on | Posted on John Murphy | Leave a Comment on More than 1,000 COVID-19 deaths recorded as US returns to April levels

Authors: BY MYCHAEL SCHNELL – 08/18/21 07:27 AM EDT The U.S. recorded more than 1,000 COVID-19 deaths on Tuesday as numbers reach levels last seen in April, largely due to the highly infectious delta variant spreading rapidly throughout the country. The 1,017 coronavirus deaths reported on Tuesday equate to roughly 42 fatalities an hour, according to a Reuters tally of state […]

COVID-19-associated diarrhea

Posted on | Posted on John Murphy | Leave a Comment on COVID-19-associated diarrhea

World J Gastroenterol. 2021 Jun 21; 27(23): 3208–3222.Published online 2021 Jun 21. doi: 10.3748/wjg.v27.i23.3208PMCID: PMC8218355PMID: 34163106 Authors: Klara Megyeri, Áron Dernovics, Zaid I I Al-Luhaibi, and András Rosztóczy Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently emerged as a highly virulent respiratory pathogen that is known as the causative agent of coronavirus disease 2019 (COVID-19). Diarrhea is a common early symptom in […]

GUT SYMPTOMS LINKED WITH COVID-19: A SYSTEMATIC REVIEW

Posted on | Posted on John Murphy | Leave a Comment on GUT SYMPTOMS LINKED WITH COVID-19: A SYSTEMATIC REVIEW

August 2021 Project: Gut microbiota could predict severity of COVID-19 Literature Review of COVID-19 G.I. Complications Authors: Md. Rayhan Mahmud, University of Helsinki, Md Karim Uddin, University of Helsinki, Md. Sajjad Hossain, Jagannath University – Bangladesh, Sharmin Akter, Jagannath University – Bangladesh Gastrointestinal Symptoms Associated With Unfavorable Prognosis of COVID-19 Patients: A Retrospective The roles of […]

ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group

Posted on | Posted on John Murphy | Leave a Comment on ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group

Authors: the ISBT COVID-19 Working Group School of Medicine Abstract Growing evidence suggests that ABO blood group may play a role in the immunopathogenesis of SARS-CoV-2 infection, with group O individuals less likely to test positive and group A conferring a higher susceptibility to infection and propensity to severe disease. The level of evidence supporting […]